[1] REGAN F,LEES C C,JONES B,et al.Prenatal management of pregnancies at risk of fetal neonatal alloimmune thrombocytopenia (FNAIT): scientific impact paper no.61[J].BJOG,2019,126(10):e173-e185. [2] OKUBO M,NISHIDA E,WATANABE A,et al.Marked thrombocytopenia in a neonate is associated with anti-HPA-5b,anti-HLA-A31,and anti-HLA-B55 antibodies[J].Pediatr Blood Cancer,2019,66(3): e27555. [3] PALMER T.Naitbabies-A patient organisation for families affected by foetal and neonatal alloimmune thrombocytopenia-FNAIT[J].Transfus Apher Sci,2020,59(1):102713. [4] KJELDSEN-KRAGH J,KILLIE M K,TOMTER G,et al.A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia[J].Blood,2007,110(3):833-839. [5] TURNER M L,BESSOS H,FAGGE T,et al.Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a[J].Transfusion,2005,45(12):1945-1956. [6] PETERMANN R,BAKCHOUL T,CURTIS B R,et al.Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH[J].J Thromb Haemost,2018,16(12):2526-2529. [7] 郝欣欣,邓晶,丛桂敏,等.胎儿/新生儿同种免疫性血小板减少症的诊断—附1例并文献复习[J].中国输血杂志,2020,33(11):1167-1172. [8] 马德冉,赵莉,田野,等.6例新生儿同种免疫性血小板减少症临床资料回顾分析[J].中国输血杂志,2020,33(10):1026-1028. [9] 邓晶,徐秀章,王嘉励,等.与母源性HLA抗体相关的新生儿同种免疫性血小板减少症——附病例报告[J].中国输血杂志,2016,29(9):935-937. [10] 王侃处,高燕,张阿维,等.新生儿同族免疫性血小板减少性紫癜2例报道[J].现代诊断与治疗,2015,26(16): 3809-3810. [11] 周燕,申卫东,刘金莲,等.第2胎抗HPA-3a抗体可使新生儿同种免疫血小板减少症患儿病情加重[J].临床检验杂志,2014,32(10):753-755. [12] 周燕,钟周琳,李丽兰,等.国内首例抗HPA-5b引发的新生儿同种免疫性血小板减少性紫癜的检测、诊断及分析[J].中国实验血液学杂志,2014,22(2):399-402. [13] 周燕,钟周琳,李丽兰,等.抗HPA-3a抗体所致新生儿同种免疫性血小板减少性紫癜一例并文献复习[J].中华血液学杂志,2013,34(1):45-48. [14] 孙国栋,于红艳,尹志柱,等.母婴血小板血型不合致新生儿血小板减少症的试验诊断[J].中国输血杂志,2011,24(12):1071-1072. [15] 宋相冬,许玉梅,武丽群.新生儿同族免疫性血小板减少性紫癜2例[J].临床荟萃,2009,24(8):726-727. [16] 温树勤,王桂君,王爱娟.新生儿同族免疫性血小板减少性紫癜3例分析[J].中国误诊学杂志,2007,7(2): 348-349. [17] 田径. 新生儿同族免疫性血小板减少性紫癜1例[J].咸宁学院学报(医学版),2006,20(3):189. [18] 覃小青,申卫东,陈云英,等.新生儿同种免疫性血小板减少症1例[J].中国输血杂志,2002,15(5):361. [19] 孙丽云,徐朝峰.新生儿同族免疫性血小板减少性紫癜2例[J].中国小儿血液,2002,7(5):227-228. [20] 侯瑞英,张成元,霍江萍,等.母亲血小板同族免疫性抗体致新生儿血小板减少性紫癜1例[J].潍坊医学院学报,2002,24(3):196. [21] 刘孟黎,郭菊莲,袁志芳,等.同种免疫致新生儿血小板减少1例[J].中国输血杂志,2000,13(2):111. [22] 成红星,闫桂香,胡荣花,陈玫. 同种免疫致新生儿血小板减少性紫癜1例[A].《中国输血杂志》编辑部.中国输血1999年年会暨纪念ABO血型发现100周年学术交流论文专辑[C].《中国输血杂志》编辑部:《中国输血杂志》编辑部,1999:2. [23] 李明珠. 新生儿同族免疫性血小板减少性紫癜3例[J].中国小儿血液,1997(05):237. [24] 陈兴长,郭瑞官.同胞兄妹新生儿同族免疫性血小板减少性紫癜2例[J].实用儿科临床杂志,1997,12(3):207-208. [25] 胡翊群,夏文权,王鸿利,等.双血小板抗原型不合引起的母婴同种免疫性血小板减少症[J].上海医学,1997,20(2):84-86. [26] 郭素义,荆鸿毅.新生儿同族免疫性血小板减少性紫癜2例[J].实用儿科临床杂志,1993,8(S1): 88. [27] 万腊香. 同种免疫性新生儿血小板减少性紫癜一例报告[J].衡阳医学院学报,1987,15(4):349-350. [28] BLANCHETTE V S,JOHNSON J,RAND M.The management of alloimmune neonatal thrombocytopenia[J].Baillieres Best Pract Res Clin Haematol,2000,13(3):365-390. [29] STANWORTH S J,ESTCOURT L J,POWTER G,et al.A no-prophylaxis platelet-transfusion strategy for hematologic cancers[J].N Engl J Med,2013,368(19): 1771-1780. [30] ESTCOURT L J,BIRCHALL J,ALLARD S,et al.Guidelines for the use of platelet transfusions[J].Br J Haematol,2017,176(3):365-394. [31] DUBRUC E,LEBRETON F,GIANNOLI C,et al.Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: a retrospective cohort study of 21 cases[J].Placenta,2016,48:104-109. [32] PORCELIJN L,HUISKES E,DE HAAS M.Progress and development of platelet antibody detection[J].Transfus Apher Sci,2020,59(1):102705. [33] FRATELLANZA G,FRATELLANZA A,PAESANO L,et al.Fetoneonatal alloimmune thrombocytopenia (FNAIT): Our experience[J].Transfus Apher Sci,2006,35(2):111-117. [34] KJÆR M,GEISEN C,AKKÖK Ç A,et al.Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia[J].Transfus Apher Sci,2020,59(1): 102712. [35] WINKELHORST D,OEPKES D.Foetal and neonatal alloimmune thrombocytopenia[J].Best Pract Res Clin Obstet Gynaecol,2019,58:15-27. [36] 刘艳,朱海峰,乔文本,等.山东汉族人群血小板抗原基因多态性分析[J].中国实验血液学杂志,2020,28(6): 2066-2070. [37] 颜廷宇,李鑫,丁镌,等.黑龙江省汉族人群血小板抗原1~17系统基因多态性研究[J].临床输血与检验,2017,19(6):623-627. [38] 李超,周永安,贾彩虹,等.山西省部分地区汉族人群血小板特异性抗原基因多态性研究[J].中国优生与遗传杂志,2017,25(4):23-25. [39] 杨帆,韩瑜,焦立新,等.吉林地区人群HPA-1~6,15系统基因多态性分析[J].中国实验诊断学,2016,20(5): 750-751. [40] 陈扬凯,叶欣,夏文杰,等.广州地区汉族人群血小板抗原基因多态性及频率分布[J].国际输血及血液学杂志,2015,38(3):207-211. [41] 尹红,杨晋渝,杨芳,等.贵州汉族人群人类血小板抗原基因多态性分析[J].中国输血杂志,2014,27(6):600-602. [42] 杨兰,梁秀云,曾江辉.广西地区壮族瑶族人群人类血小板抗原基因的多态性分析[J].检验医学与临床,2013,10(20): 2644-2645. [43] 张刚,曹丽群,谢毓滨,等.长沙地区汉族人血小板抗原(HPA1-17)基因多态性调查[J].中国实验诊断学,2013,17(2):331-333. [44] 沈彤,冯明亮,印彪,等.汉族人群人类血小板抗原-1系统a/b/x等位基因多态性调查[J].临床血液学杂志(输血与检验版),2010,23(6):321-323. [45] 陈语嫣,龚祖康,林文珍.中国地区汉族人类血小板抗原基因多态性研究[J].基因组学与应用生物学,2017,36(2):433-444. [46] 李鑫,颜廷宇,芦凤亮,等.黑龙江省满族人群血小板抗原1~17系统基因多态性的研究[J].国际免疫学杂志,2016,39(2):126-130. [47] 李梦丹,王珏,宋宁,等.拉萨藏族献血人群HPA-1~6、15基因多态性[J].中国输血杂志,2013,26(6):514-517. [48] CURTIS B R.Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia[J].Br J Haematol,2015,171(5): 671-682. [49] SONNEVELD M E,NATUNEN S,SAINIO S,et al.Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia[J].Br J Haematol,2016,174(2):310-320. [50] SACHS U J,WIENZEK-LISCHKA S,DUONG Y,et al.Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia[J].Br J Haematol,2020,189(4):751-759. [51] 张军,王彩莲,陈丽,等.皖北地区1025例孕妇抗-HPA抗体的初步研究[J].中国免疫学杂志,2020,36(5): 611-617. [52] 周助人,李剑平.CD36基因缺失与同种免疫性血小板减少症关系的研究进展[J].吉林大学学报(医学版),2012,38(6):1232-1235. [53] 尼岸悦子, 林智也, 高陽淑,等. CD36抗体検出のための新たな検査方法の樹立[J]. 日本輸血細胞治療学会誌, 2014, 60(6):609-613. [54] 杨卫华,王燕宁,高明.血小板非特异性抗原CD36缺失与免疫性血小板减少的相关性研究进展[J].西北国防医学杂志,2015,36(4):251-253. [55] LIEBERMAN L,GREINACHER A,MURPHY M F,et al.Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice,an international approach[J].Br J Haematol,2019,185(3): 549-562. [56] 陈焰. 超声监测围产期胎儿、新生儿脑损伤及颅内出血的研究[J].中华围产医学杂志,2001,4(4): 215-217. [57] 李莉,张智荣,魏丽,等.高危新生儿脑损伤早期诊断中经颅脑超声的临床价值分析[J].基层医学论坛,2017,21(22):2974-2975. [58] COLE L,DEWEY D,LETOURNEAU N,et al.Clinical characteristics,risk factors,and outcomes associated with neonatal hemorrhagic stroke: a population-based case-control study[J].JAMA Pediatr,2017,171(3): 230-238. [59] VERGANI P,STROBELT N,LOCATELLI A,et al.Clinical significance of fetal intracranial hemorrhage[J].Am J Obstet Gynecol,1996,175(3 pt 1): 536-543. |